Iptacopan is a complement factor B inhibitor targeting the overactive alternative complement pathway in IgA nephropathy.

MediBeacon has received the CE Mark certification under the European Union (EU) Medical Device Regulation (MDR) for its ...

Using a registry of real-world patients with lupus nephritis, investigators studied trajectories of kidney function decline over a decade.

Basel, March 29, 2026 – Novartis today announced final two-year results from the Phase III APPLAUSE‑IgAN study of Fabhalta ® (iptacopan) in IgA nephropathy (IgAN). Fabhalta demonstrated a ...

Scientists at the Buck Institute for Research on Aging have shown that an orally administered small molecule, ...

Are your kidneys working fine, or have they stopped working? Scroll down to know the top 5 often ignored signs of kidney ...

One drink was the clear winner. Here’s why you should start your day with it.